Related references
Note: Only part of the references are listed.Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Tanaya Shree et al.
GENES & DEVELOPMENT (2011)
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Yuchen Chien et al.
GENES & DEVELOPMENT (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
DNA Damage-Mediated Induction of a Chemoresistant Niche
Luke A. Gilbert et al.
CELL (2010)
WNT16B Is a New Marker of Cellular Senescence That Regulates p53 Activity and the Phosphoinositide 3-Kinase/AKT Pathway
Romuald Binet et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
SASPense and DDRama in cancer and ageing
Marzia Fumagalli et al.
NATURE CELL BIOLOGY (2009)
Senescence-messaging secretome: SMS-ing cellular stress
Thomas Kuilman et al.
NATURE REVIEWS CANCER (2009)
The Activated NF-kappa B-Snail-RKIP Circuitry in Cancer Regulates Both the Metastatic Cascade and Resistance to Apoptosis by Cytotoxic Drugs
Katherine Wu et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network
Thomas Kuilman et al.
CELL (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Chemokine signaling via the CXCR2 receptor reinforces senescence
Juan C. Acosta et al.
CELL (2008)
The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression
Elizabeth Vincan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
Resistance mechanisms to cancer chemotherapy
Kelly Marie Redmond et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
Swati Biswas et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli
Craig M. Berchtold et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells
Jong In Yook et al.
NATURE CELL BIOLOGY (2006)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence
Jean-Philippe Coppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer
M Garzotto et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms
C Bavik et al.
CANCER RESEARCH (2006)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Repopulation of cancer cells during therapy: An important cause of treatment failure
JJ Kim et al.
NATURE REVIEWS CANCER (2005)
Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo
A Helmrich et al.
ONCOGENE (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer
TM Beer et al.
CLINICAL CANCER RESEARCH (2004)
Involvement of Rd/nuclear factor-κB transcription factors in keratinocyte senescence
D Bernard et al.
CANCER RESEARCH (2004)
Chemotherapy sensitivity and resistance assays: A systematic review
DJ Samson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Chemotherapy response and resistance
S Lee et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2003)
Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts
F Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Genetic analysis of chemoresistance in primary murine lymphomas
CA Schmitt et al.
NATURE MEDICINE (2000)
Share Paper
